{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:10:01Z","timestamp":1793239801449,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05785-5","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T10:04:00Z","timestamp":1730196240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Jiayi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoran","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-9406","authenticated-orcid":false,"given":"Cheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"issue":"8","key":"5785_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1517\/14656566.2014.903923","volume":"15","author":"RP Wuthrich","year":"2014","unstructured":"Wuthrich RP, Mei C. Pharmacological management of polycystic kidney disease. Expert Opin Pharmacother. 2014;15(8):1085\u201395.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"5785_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000535750","volume":"49","author":"M Yang","year":"2024","unstructured":"Yang M, Lv J, Gong C, Xue C, Fu L, Chen S, Mei C. Inflammation is more sensitive than cell proliferation in response to Rapamycin treatment in polycystic kidney disease. Kidney Blood Press Res. 2024;49(1):60\u20138.","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"5785_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/ndt\/gfs524","volume":"28","author":"F Kotsis","year":"2013","unstructured":"Kotsis F, Boehlke C, Kuehn EW. The ciliary flow sensor and polycystic kidney disease. Nephrol dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association. 2013;28(3):518\u201326.","journal-title":"Nephrol dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association"},{"issue":"6","key":"5785_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/wdev.152","volume":"3","author":"BM Paul","year":"2014","unstructured":"Paul BM, Vanden Heuvel GB. Kidney: polycystic kidney disease. Wiley Interdisciplinary Reviews Dev Biology. 2014;3(6):465\u201387.","journal-title":"Wiley Interdisciplinary Reviews Dev Biology"},{"issue":"10","key":"5785_CR5","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","volume":"1812","author":"DP Wallace","year":"2011","unstructured":"Wallace DP. Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta. 2011;1812(10):1291\u2013300.","journal-title":"Biochim Biophys Acta"},{"key":"5785_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fphys.2015.00121","volume":"6","author":"N Liu","year":"2015","unstructured":"Liu N, Zhuang S. Treatment of chronic kidney diseases with histone deacetylase inhibitors. Front Physiol. 2015;6:121.","journal-title":"Front Physiol"},{"issue":"10","key":"5785_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bbadis.2010.10.008","volume":"1812","author":"X Li","year":"2011","unstructured":"Li X. Epigenetics and autosomal dominant polycystic kidney disease. Biochim Biophys Acta. 2011;1812(10):1213\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"5785_CR8","doi-asserted-by":"publisher","first-page":"921631","DOI":"10.3389\/fmed.2022.921631","volume":"9","author":"J Xu","year":"2022","unstructured":"Xu J, Xue C, Wang X, Zhang L, Mei C, Mao Z. Chromatin Methylation Abnormalities in autosomal Dominant polycystic kidney disease. Front Med. 2022;9:921631.","journal-title":"Front Med"},{"issue":"7","key":"5785_CR9","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1172\/JCI64401","volume":"123","author":"X Zhou","year":"2013","unstructured":"Zhou X, Fan LX, Sweeney WE Jr., Denu JM, Avner ED, Li X. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J Clin Invest. 2013;123(7):3084\u201398.","journal-title":"J Clin Invest"},{"issue":"14","key":"5785_CR10","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/hmg\/ddv136","volume":"24","author":"X Zhou","year":"2015","unstructured":"Zhou X, Fan LX, Peters DJ, Trudel M, Bradner JE, Li X. Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD. Hum Mol Genet. 2015;24(14):3982\u201393.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"5785_CR11","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1172\/JCI90921","volume":"127","author":"LX Li","year":"2017","unstructured":"Li LX, Fan LX, Zhou JX, Grantham JJ, Calvet JP, Sage J, Li X. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. J Clin Investig. 2017;127(7):2751\u201364.","journal-title":"J Clin Investig"},{"issue":"8","key":"5785_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2174\/1568026615666150302105207","volume":"15","author":"SK Verma","year":"2015","unstructured":"Verma SK. Inhibition of the histone lysine methyltransferase EZH2 for the treatment of cancer. Curr Top Med Chem. 2015;15(8):714\u20139.","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"5785_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/jb\/mvu054","volume":"156","author":"Y Kondo","year":"2014","unstructured":"Kondo Y. Targeting histone methyltransferase EZH2 as cancer treatment. J Biochem. 2014;156(5):249\u201357.","journal-title":"J Biochem"},{"issue":"1","key":"5785_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1039\/D1MD00274K","volume":"13","author":"KL Liu","year":"2022","unstructured":"Liu KL, Zhu K, Zhang H. An overview of the development of EED inhibitors to disable the PRC2 function. RSC Med Chem. 2022;13(1):39\u201353.","journal-title":"RSC Med Chem"},{"issue":"5","key":"5785_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/joim.12214","volume":"276","author":"Z Su","year":"2014","unstructured":"Su Z, Wang X, Gao X, Liu Y, Pan C, Hu H, Beyer RP, Shi M, Zhou J, Zhang J, et al. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med. 2014;276(5):470\u201385.","journal-title":"J Intern Med"},{"issue":"52","key":"5785_CR16","doi-asserted-by":"publisher","first-page":"15988","DOI":"10.1073\/pnas.1521740112","volume":"112","author":"J Yin","year":"2015","unstructured":"Yin J, Leavenworth JW, Li Y, Luo Q, Xie H, Liu X, Huang S, Yan H, Fu Z, Zhang LY, et al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc Natl Acad Sci USA. 2015;112(52):15988\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"5785_CR17","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1681\/ASN.2018010074","volume":"29","author":"Y Yang","year":"2018","unstructured":"Yang Y, Chen M, Zhou J, Lv J, Song S, Fu L, Chen J, Yang M, Mei C. Interactions between macrophages and Cyst-lining epithelial cells promote kidney cyst growth in Pkd1-Deficient mice. J Am Soc Nephrol. 2018;29(9):2310\u201325.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5785_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000104818","volume":"30","author":"M Wu","year":"2007","unstructured":"Wu M, Wahl PR, Le Hir M, Wackerle-Men Y, Wuthrich RP, Serra AL. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press Res. 2007;30(4):253\u20139.","journal-title":"Kidney Blood Press Res"},{"issue":"51","key":"5785_CR19","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1073\/pnas.0911987106","volume":"106","author":"Y Cao","year":"2009","unstructured":"Cao Y, Semanchik N, Lee SH, Somlo S, Barbano PE, Coifman R, Sun Z. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci U S A. 2009;106(51):21819\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5785_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00439-013-1378-0","volume":"133","author":"YM Woo","year":"2014","unstructured":"Woo YM, Bae JB, Oh YH, Lee YG, Lee MJ, Park EY, Choi JK, Lee S, Shin Y, Lyu J, et al. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development. Hum Genet. 2014;133(3):281\u201397.","journal-title":"Hum Genet"},{"issue":"11","key":"5785_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","volume":"17","author":"S Shibazaki","year":"2008","unstructured":"Shibazaki S, Yu Z, Nishio S, Tian X, Thomson RB, Mitobe M, Louvi A, Velazquez H, Ishibe S, Cantley LG, et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet. 2008;17(11):1505\u201316.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"5785_CR22","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1093\/hmg\/ddt672","volume":"23","author":"G Yao","year":"2014","unstructured":"Yao G, Su X, Nguyen V, Roberts K, Li X, Takakura A, Plomann M, Zhou J. Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex. Hum Mol Genet. 2014;23(10):2769\u201379.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"5785_CR23","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2018020125","volume":"29","author":"H Wu","year":"2018","unstructured":"Wu H, Malone AF, Donnelly EL, Kirita Y, Uchimura K, Ramakrishnan SM, Gaut JP, Humphreys BD. Single-cell transcriptomics of a human kidney allograft Biopsy Specimen defines a diverse inflammatory response. J Am Soc Nephrol. 2018;29(8):2069\u201380.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5785_CR24","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1038\/s41467-022-34255-z","volume":"13","author":"Y Muto","year":"2022","unstructured":"Muto Y, Dixon EE, Yoshimura Y, Wu H, Omachi K, Ledru N, Wilson PC, King AJ, Eric Olson N, Gunawan MG, et al. Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis. Nat Commun. 2022;13(1):6497.","journal-title":"Nat Commun"},{"issue":"12","key":"5785_CR25","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1681\/ASN.2006030295","volume":"17","author":"BS Magenheimer","year":"2006","unstructured":"Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP, Maser RL, Grantham JJ, Calvet JP. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+),K(+),2Cl(-) co-transporter-dependent cystic dilation. J Am Soc Nephrology: JASN. 2006;17(12):3424\u201337.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"3","key":"5785_CR26","doi-asserted-by":"publisher","first-page":"F479","DOI":"10.1152\/ajprenal.00329.2017","volume":"315","author":"Y Jing","year":"2018","unstructured":"Jing Y, Wu M, Zhang D, Chen D, Yang M, Mei S, He L, Gu J, Qi N, Fu L, et al. Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway. Am J Physiol Ren Physiol. 2018;315(3):F479\u201386.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"5785_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbrc.2007.10.044","volume":"364","author":"S Vougier","year":"2007","unstructured":"Vougier S, Cheung SH, Li L, Hodgson G, Shaw PE. Anomalous behaviour of the STAT3 binding site in the human c-myc P2 promoter. Biochem Biophys Res Commun. 2007;364(3):627\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"5785_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321\u201337.","journal-title":"Annu Rev Med"},{"issue":"20","key":"5785_CR29","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","volume":"22","author":"AP Bracken","year":"2003","unstructured":"Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 2003;22(20):5323\u201335.","journal-title":"EMBO J"},{"key":"5785_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11255-018-1951-5","volume":"51","author":"DX Ke Sun","year":"2019","unstructured":"Ke Sun DX. The association between autosomal dominant polycystic kidney disease and cancer. Int Urol Nephrol. 2019;51:93\u2013100.","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"5785_CR31","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00109-012-0902-3","volume":"90","author":"G Aguiari","year":"2012","unstructured":"Aguiari G, Bizzarri F, Bonon A, Mangolini A, Magri E, Pedriali M, Querzoli P, Somlo S, Harris PC, Catizone L, et al. Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation. J Mol Med. 2012;90(11):1267\u201382.","journal-title":"J Mol Med"},{"issue":"3","key":"5785_CR32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM Jr., Grantham JJ. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004;66(3):964\u201373.","journal-title":"Kidney Int"},{"issue":"58","key":"5785_CR33","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1038\/onc.2008.333","volume":"27","author":"Q Cao","year":"2008","unstructured":"Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Kleer CG, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008;27(58):7274\u201384.","journal-title":"Oncogene"},{"issue":"1","key":"5785_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10549-011-1396-3","volume":"131","author":"J Du","year":"2012","unstructured":"Du J, Li L, Ou Z, Kong C, Zhang Y, Dong Z, Zhu S, Jiang H, Shao Z, Huang B, et al. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Breast Cancer Res Treat. 2012;131(1):65\u201373.","journal-title":"Breast Cancer Res Treat"},{"issue":"7078","key":"5785_CR35","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vire","year":"2006","unstructured":"Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871\u20134.","journal-title":"Nature"},{"issue":"1","key":"5785_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-022-01235-1","volume":"15","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Gholami MH, Hushmandi K, Hshemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, et al. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol. 2022;15(1):18.","journal-title":"J Hematol Oncol"},{"issue":"13","key":"5785_CR37","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1073\/pnas.1503152112","volume":"112","author":"M Dasgupta","year":"2015","unstructured":"Dasgupta M, Dermawan JK, Willard B, Stark GR. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Proc Natl Acad Sci U S A. 2015;112(13):3985\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"5785_CR38","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s00018-015-2001-4","volume":"72","author":"X Zhang","year":"2015","unstructured":"Zhang X, Huang Y, Shi X. Emerging roles of lysine methylation on non-histone proteins. Cell Mol Life Sci. 2015;72(22):4257\u201372.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"5785_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.molcel.2013.08.028","volume":"52","author":"HY Jung","year":"2013","unstructured":"Jung HY, Jun S, Lee M, Kim HC, Wang X, Ji H, McCrea PD, Park JI. PAF and EZH2 induce Wnt\/beta-catenin signaling hyperactivation. Mol Cell. 2013;52(2):193\u2013205.","journal-title":"Mol Cell"},{"issue":"2","key":"5785_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22(2):128\u201334.","journal-title":"Nat Med"},{"issue":"6","key":"5785_CR41","doi-asserted-by":"publisher","first-page":"152374","DOI":"10.1016\/j.prp.2019.03.003","volume":"215","author":"J Xu","year":"2019","unstructured":"Xu J, Wang Z, Lu W, Jiang H, Lu J, Qiu J, Ye G. EZH2 promotes gastric cancer cells proliferation by repressing p21 expression. Pathol Res Pract. 2019;215(6):152374.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"5785_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","volume":"9","author":"T Fan","year":"2011","unstructured":"Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC, Hornyak TJ. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression. Mol Cancer Res. 2011;9(4):418\u201329.","journal-title":"Mol Cancer Res"},{"issue":"46","key":"5785_CR43","doi-asserted-by":"publisher","first-page":"29001","DOI":"10.1073\/pnas.2009334117","volume":"117","author":"EJ Lee","year":"2020","unstructured":"Lee EJ, Seo E, Kim JW, Nam SA, Lee JY, Jun J, Oh S, Park M, Jho EH, Yoo KH, et al. TAZ\/Wnt-beta-catenin\/c-MYC axis regulates cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A. 2020;117(46):29001\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"5785_CR44","doi-asserted-by":"publisher","first-page":"107630","DOI":"10.1016\/j.isci.2023.107630","volume":"26","author":"AH Ghobashi","year":"2023","unstructured":"Ghobashi AH, Vuong TT, Kimani JW, Ladaika CA, Hollenhorst PC, O\u2019Hagan HM. Activation of AKT induces EZH2-mediated beta-catenin trimethylation in colorectal cancer. iScience. 2023;26(9):107630.","journal-title":"iScience"},{"issue":"11","key":"5785_CR45","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1681\/ASN.2021040460","volume":"32","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li LX, Ding H, Torres VE, Yu C, Li X. Ferroptosis promotes cyst growth in autosomal Dominant polycystic kidney Disease Mouse models. J Am Soc Nephrol. 2021;32(11):2759\u201376.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5785_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-023-04793-1","volume":"22","author":"X Yan","year":"2024","unstructured":"Yan X, Xia Y, Li B, Ye Z, Li L, Yuan T, Song B, Yu W, Rao T, Ning J, et al. The SOX4\/EZH2\/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury. J Translational Med. 2024;22(1):9.","journal-title":"J Translational Med"},{"key":"5785_CR47","doi-asserted-by":"publisher","first-page":"741302","DOI":"10.3389\/fimmu.2021.741302","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang J, Guo Z, Li C, Tan Z, Wang J, Yang J, Xue L. Easy or not-the advances of EZH2 in regulating T cell development, differentiation, and activation in Antitumor Immunity. Front Immunol. 2021;12:741302.","journal-title":"Front Immunol"},{"issue":"11","key":"5785_CR48","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nchembio.1084","volume":"8","author":"SK Knutson","year":"2012","unstructured":"Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR, Sacks JD, Raimondi A, Majer CR, Song J, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol. 2012;8(11):890\u20136.","journal-title":"Nat Chem Biol"},{"key":"5785_CR49","doi-asserted-by":"publisher","first-page":"104972","DOI":"10.1016\/j.ebiom.2024.104972","volume":"100","author":"Y Guo","year":"2024","unstructured":"Guo Y, Cheng R, Wang Y, Gonzalez ME, Zhang H, Liu Y, Kleer CG, Xue L. Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. EBioMedicine. 2024;100:104972.","journal-title":"EBioMedicine"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05785-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T13:05:46Z","timestamp":1730293546000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05785-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5785"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05785-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted according to the guidelines of and approved by the Animal Research Committee of the Naval Medical University. Informed consent was obtained from all subjects. The study was approved by the ethics review board of Changzheng Hospital (CZ2018-0619). The study abided by the Declaration of Helsinki principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"979"}}